{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:51:15Z","timestamp":1794210675793,"version":"4.8.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajog.2022.04.044","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T11:40:12Z","timestamp":1651232412000},"page":"506.e1-506.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies"],"prefix":"10.1016","volume":"227","author":[{"given":"Siw L.","family":"Ernstsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3104-3818","authenticated-orcid":false,"given":"Maria T.","family":"Ahlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiril","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-0205","authenticated-orcid":false,"given":"Eirin L.","family":"Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Kjeldsen-Kragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-0750","authenticated-orcid":false,"given":"Heidi","family":"Tiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2022.04.044_bib1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJM199311113292005","article-title":"Fetal thrombocytopenia and its relation to maternal thrombocytopenia","volume":"329","author":"Burrows","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib2","first-page":"441","article-title":"Thrombocytopenia in term infants: a population-based study","volume":"95","author":"Sainio","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.2013-3320","article-title":"Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review","volume":"133","author":"Kamphuis","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2022.04.044_bib4","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1423-0410.2003.00302.x","article-title":"Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?","volume":"84","author":"Radder","year":"2003","journal-title":"Vox Sang"},{"key":"10.1016\/j.ajog.2022.04.044_bib6","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1537-2995.2004.04026.x","article-title":"Human platelet antigen-specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia","volume":"44","author":"Davoren","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2022.04.044_bib7","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/blood.V92.7.2280","article-title":"The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening","volume":"92","author":"Williamson","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib8","first-page":"CD004226","article-title":"Antenatal interventions for fetomaternal alloimmune thrombocytopenia","volume":"11","author":"Rayment","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2022.04.044_bib9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib10","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bjh.15813","article-title":"Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach","volume":"185","author":"Lieberman","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2022.04.044_bib11","doi-asserted-by":"crossref","first-page":"102711","DOI":"10.1016\/j.transci.2019.102711","article-title":"Fetal and neonatal alloimmune thrombocytopenia\u2014the Norwegian management model","volume":"59","author":"Tiller","year":"2020","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.ajog.2022.04.044_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002490","article-title":"Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry","volume":"3","author":"Tiller","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2022.04.044_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2006-08-040121","article-title":"A\u00a0screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia","volume":"110","author":"Kjeldsen-Kragh","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3324\/haematol.12515","article-title":"A\u00a0prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn","volume":"93","author":"Killie","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2022.04.044_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2022.04.044_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2006.06.066","article-title":"Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage","volume":"195","author":"Yinon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2003.00188.x","article-title":"Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period","volume":"82","author":"Tiblad","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2022.04.044_bib20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2022.04.044_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034071","article-title":"HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal\/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk","volume":"10","author":"Winkelhorst","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2022.04.044_bib22","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MOH.0b013e3283317be9","article-title":"Is it time to implement HPA-1 screening in pregnancy?","volume":"16","author":"Husebekk","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ajog.2022.04.044_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/ATVBAHA.116.307281","article-title":"Antiendothelial \u03b1v\u03b23 antibodies are a major cause of intracranial bleeding in fetal\/neonatal alloimmune thrombocytopenia","volume":"36","author":"Santoso","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2022.04.044_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12725","article-title":"Maternal HPA-1a antibody level and its role in predicting the severity of fetal\/neonatal alloimmune thrombocytopenia: a systematic review","volume":"114","author":"Kjaer","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.ajog.2022.04.044_bib25","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A\u00a0prominent lack of IgG1-Fc fucosylation of platelet\u00a0alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","article-title":"New developments in fetal and neonatal alloimmune thrombocytopenia","volume":"225","author":"Bussel","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib27","first-page":"1783","article-title":"Effects of antepartum therapy for fetal alloimmune thrombocytopenia on maternal lifestyle","volume":"29","author":"Rossi","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00404-020-05618-y","article-title":"Non-invasive risk-assessment and bleeding prophylaxis with IVIG in pregnant women with a history of fetal and neonatal alloimmune thrombocytopenia: management to minimize adverse events","volume":"302","author":"Wienzek-Lischka","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2022.04.044_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/AOG.0b013e3182765c63","article-title":"Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia","volume":"121","author":"Rink","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib30","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1055\/s-0037-1607055","article-title":"IVIG-associated maternal pancytopenia during treatment for neonatal alloimmune thrombocytopenia","volume":"7","author":"Herrmann","year":"2017","journal-title":"AJP Rep"},{"key":"10.1016\/j.ajog.2022.04.044_bib32","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2016-10-739656","article-title":"Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review","volume":"129","author":"Winkelhorst","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000380907","article-title":"Low-dose versus standard-dose intravenous immunoglobulin to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia: a randomized trial","volume":"38","author":"Paridaans","year":"2015","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2022.04.044_bib34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/01.AOG.0000270302.80336.dd","article-title":"Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial","volume":"110","author":"Berkowitz","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.AOG.0000192404.25780.68","article-title":"Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia","volume":"107","author":"Berkowitz","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9378(96)70582-3","article-title":"Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin","volume":"174","author":"Bussel","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000089048","article-title":"Intravenous immunoglobulins without initial and follow-up cordocentesis in alloimmune fetal and neonatal thrombocytopenia at high risk for intracranial hemorrhage","volume":"21","author":"Kanhai","year":"2006","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2022.04.044_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1538-7836.2006.01809.x","article-title":"Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia","volume":"4","author":"Bertrand","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.ajog.2022.04.044_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.earlhumdev.2004.05.007","article-title":"Follow up of children after antenatal treatment for alloimmune thrombocytopenia","volume":"80","author":"Radder","year":"2004","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.ajog.2022.04.044_bib40","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1067\/mob.2000.104841","article-title":"Neonatal alloimmune thrombocytopenia: antenatal management","volume":"182","author":"Silver","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib41","first-page":"67","article-title":"Antenatal treatment of alloimmune thrombocytopenia","volume":"80","author":"Lynch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib42","first-page":"66","article-title":"Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin","volume":"13","author":"Van Der Lugt","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.ajog.2022.04.044_bib43","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood-2010-08-302463","article-title":"Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia","volume":"117","author":"Bertrand","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ajog.2022.04.044_bib44","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3109\/14767058.2010.511333","article-title":"Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?","volume":"24","author":"Mechoulan","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib45","doi-asserted-by":"crossref","first-page":"135.e1","DOI":"10.1016\/j.ajog.2010.03.011","article-title":"Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus","volume":"203","author":"Bussel","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib46","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1423-0410.2010.01367.x","article-title":"Repeated intrauterine IgG infusions in foetal alloimmune thrombocytopenia do not increase foetal platelet counts","volume":"99","author":"Giers","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.ajog.2022.04.044_bib47","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00431-006-0389-4","article-title":"Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG","volume":"166","author":"te Pas","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ajog.2022.04.044_bib48","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1471-0528.2007.01244.x","article-title":"Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective","volume":"114","author":"van den Akker","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2022.04.044_bib49","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1537-2995.2007.01208.x","article-title":"Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia","volume":"47","author":"Ghevaert","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2022.04.044_bib50","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.ajog.2006.06.066","article-title":"Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage","volume":"195","author":"Yinon","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib51","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1034\/j.1600-0412.2003.00188.x","article-title":"Experiences with fetomaternal alloimmune thrombocytopenia at a Swedish hospital over a 10-year period","volume":"82","author":"Tiblad","year":"2003","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2022.04.044_bib52","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1046\/j.1365-2141.2003.04408.x","article-title":"European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia","volume":"122","author":"Birchall","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2022.04.044_bib53","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-3148.1999.00216.x","article-title":"Prenatal treatment of severe fetomaternal alloimmune thrombocytopenia","volume":"9","author":"Sainio","year":"1999","journal-title":"Transfus Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib54","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1046\/j.1365-2141.1998.00533.x","article-title":"Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT","volume":"100","author":"Kaplan","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2022.04.044_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000264304","article-title":"Antenatal invasive and noninvasive management of alloimmune thrombocytopenia","volume":"11","author":"Kornfeld","year":"1996","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2022.04.044_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-3148.1994.tb00265.x","article-title":"Antenatal management of fetomaternal alloimmune thrombocytopenia--report of 15 affected pregnancies","volume":"4","author":"Murphy","year":"1994","journal-title":"Transfus Med"},{"key":"10.1016\/j.ajog.2022.04.044_bib57","first-page":"433","article-title":"Antenatal treatment of fetal alloimmune thrombocytopenia","volume":"80","author":"Wenstrom","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2022.04.044_bib58","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1182\/blood.V72.1.340.340","article-title":"Management of alloimmune thrombocytopenia: antenatal diagnosis and in utero transfusion of maternal platelets","volume":"72","author":"Kaplan","year":"1988","journal-title":"Blood"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822003258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937822003258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:37:27Z","timestamp":1757590647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937822003258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0002937822003258"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2022.04.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antenatal intravenous immunoglobulins in pregnancies at risk of fetal and neonatal alloimmune thrombocytopenia: comparison of neonatal outcome in treated and nontreated pregnancies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2022.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}